Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy Regimens.

about

Comparison of the Control of Nausea and Vomiting among Several Moderately Emetic-Risk Chemotherapy Regimens.

Item

http://www.wikidata.org/entity/Q36764931

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@ast

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@en

type

Item

label

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@ast

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@en

prefLabel

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@ast

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@en

P1476

Comparison of the Control of N ...... ic-Risk Chemotherapy Regimens.

@en

P2093

Akio Suzuki

http://www.w3.org/2001/XMLSchema#string

Chiaki Yoshimi

http://www.w3.org/2001/XMLSchema#string

Hironori Fujii

http://www.w3.org/2001/XMLSchema#string

Kazuhiro Yoshida

http://www.w3.org/2001/XMLSchema#string

Kazuya Yamaguchi

http://www.w3.org/2001/XMLSchema#string

Manabu Futamura

http://www.w3.org/2001/XMLSchema#string

Masashi Ishihara

http://www.w3.org/2001/XMLSchema#string

Maya Yamada

http://www.w3.org/2001/XMLSchema#string

Yoshinori Itoh

http://www.w3.org/2001/XMLSchema#string

P2860

Asenapine: a novel psychopharmacologic agent with a unique human receptor signature

Incidence of chemotherapy-induced nausea and vomiting with moderately emetogenic chemotherapy: ADVICE (Actual Data of Vomiting Incidence by Chemotherapy Evaluation) study.

Antiemetics: American Society of Clinical Oncology clinical practice guideline update.

Anticipatory nausea and vomiting due to chemotherapy.

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference.

Chemotherapy-induced nausea and vomiting in daily clinical practice: a community hospital-based study.

Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial.

The impact of chemotherapy-related nausea on patients' nutritional status, psychological distress and quality of life.

Prevention of delayed nausea: a University of Rochester Cancer Center Community Clinical Oncology Program study of patients receiving chemotherapy.

Japanese Society of Clinical Oncology clinical practice guidelines 2010 for antiemesis in oncology: executive summary.

P304

569-575

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.7150/JCA.13637

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Hirotoshi Iihara

P577

2016-03-18T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27053955

http://www.w3.org/2001/XMLSchema#string

P932

4820733

http://www.w3.org/2001/XMLSchema#string